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Aromatic and basic residues within the EVH1 domain of VASP
specify its interaction with proline-rich ligands
Uwe D. Carl*, Marc Pollmann*, Elisha Orr†, Frank B. Gertler‡, 
Trinad Chakraborty§ and Juergen Wehland*
Short contiguous peptides harboring proline-rich
motifs are frequently involved in protein–protein
interactions, such as associations with Src homology 3
(SH3) and WW domains. Although patches of aromatic
residues present in either domain interact with
polyprolines, their overall structures are distinct,
suggesting that additional protein families exist that
use stacked aromatic amino acids (AA domains) to
bind polyproline motifs [1–3]. A polyproline motif
(E/DFPPPPTD/E in the single-letter amino-acid code),
present in the ActA protein of the intracellular bacterial
pathogen Listeria monocytogenes, serves as a ligand
for the Ena/VASP protein family — the vasodilator-
stimulated phosphoprotein (VASP), the murine protein
Mena, Drosophila Enabled (Ena) and the Ena/VASP-
like protein Evl [4–7]. These share a similar overall
structure characterized by the two highly conserved
Ena/VASP homology domains (EVH1 and EVH2) [5].
Here, using three independent assays, we have
delineated the minimal EVH1 domain. Mutations of
aromatic and basic residues within two conserved
hydrophilic regions of the EVH1 domain abolished
binding to ActA. Binding of an EVH1 mutant with
reversed charges could partially be rescued by
introducing complementary mutations within the
ligand. Like SH3 domains, aromatic residues within the
EVH1 domain interacted with polyprolines, whereas the
ligand specificity of either domain was determined by
reciprocally charged residues. The EVH1 domain is
therefore a new addition to the AA domain superfamily,
which includes SH3 and WW domains.
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Results and discussion
Using the yeast two-hybrid system, sequentially truncated
carboxy-terminal and amino-terminal derivatives of VASP,
Mena and Evl fused to the transcriptional activation
domain of GAL4 (AD) were assessed for their ability to
bind to different ActA derivatives fused to the GAL4
DNA-binding domain (BD). All fusion proteins that were
truncated at the carboxyl terminus were able to bind ActA
except those that were shorter than the predicted EVH1
domain (Table 1). Two VASP–AD fusion proteins that
were truncated at the amino termins, VASP56–380 and
VASP106–380, failed to bind to ActA, confirming the require-
ment of the amino-terminal domain of VASP (Table 1).
To corroborate these results, we transfected PtK2 cells with
plasmids expressing VASP, Mena or Evl derivatives fused
Table 1
Interactions of truncated derivatives of Mena, Evl and VASP
with each other and ActA. 
VASP–AD + – + + + +
VASP1–304–AD + – – – n.d. n.d.
VASP1–192–AD + – – – n.d. n.d.
VASP1–149–AD + – – – n.d. n.d.
VASP1–116–AD + – – – – –
VASP1–98–AD – – – – n.d. n.d.
VASP1–79–AD – – – – n.d. n.d.
VASP56–380–AD – – + + + +
VASP106–380–AD – – + + + +
Mena–AD + – + + + +
Mena1–196–AD + – – – n.d. n.d.
Mena1–154–AD + – – – n.d. n.d.
Mena1–114–AD + – – – n.d. n.d.
Mena1–96–AD – – – – n.d. n.d.
Evl–AD + – + + + +
Evl1–148–AD + – – – n.d. n.d.
Evl1–117–AD + – – – n.d. n.d.
Evl1–96–AD – – – – n.d. n.d.
Data were determined using the yeast two-hybrid system. See
Supplementary material for diagrams of the truncated proteins and the
yeast two-hybrid data. The numbers indicate amino-acid positions.
ActA7–263–BD, which lacks the polyproline motifs, served as a control.
+, an interaction; –, no interaction; n.d., not determined.
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to the green fluorescent protein (GFP). As shown for
GFP–VASP (Figure 1a), all fusion proteins were localized
in the focal adhesions of transfected cells, as long as the
respective GFP fusion protein carried the complete EVH1
domain (data not shown). To determine the extent that
these fusion proteins could be recruited by intracellular
L. monocytogenes, we infected the transfected cells with
L. monocytogenes wild-type strain EGD. Intracellular bacteria
accumulated full-length GFP–VASP1–380 and the carboxy-
terminally truncated GFP–VASP1–116, GFP–Mena1–114 and
GFP–Evl1–117 fusion proteins on their surface
(Figure 1a–d). In contrast, GFP–VASP1–98, which did not
have an intact EVH1 domain, was not detectable on intra-
cellular bacteria (Figure 1e).
To determine in vitro binding to ActA, the VASP, Mena
and Evl derivatives shown in Table 1 were produced in a
protein translation system using [35S]methionine and sub-
sequently analyzed in an affinity-binding assay with
immobilized ActA. Full-length Mena, and its derivatives
carrying the EVH1 domain, bound ActA strongly whereas
virtually no labeled protein was retained by the ActA affin-
ity matrix when Mena1–96 was used (Figure 2). Similar
results were obtained with corresponding Evl derivatives.
In contrast, only full-length VASP was retained by the
ActA affinity matrix, suggesting that, unlike Mena and
Evl, the activity of the VASP EVH1 domain depends on
the integrity of the EVH2 domain (see below). The deriv-
ative Mena14–541 showed no detectable binding to immo-
bilized ActA (Figure 2), suggesting that the domain
required for the interaction with ActA extends into the
very amino-terminal region of Ena/VASP proteins.
Together, these results allowed us to delineate the EVH1
domains of VASP, Mena and Evl to within their amino-ter-
minal 116, 114 and 117 amino acids, respectively.
The differences in VASP binding observed in the two-
hybrid system and the in vitro binding assay could be the
result of a requirement for the EVH2 domain. We there-
fore constructed plasmids that express full-length VASP
(VASP–BD) or its EVH2 domain (VASP227–380–BD) fused
to BD. Both fusion proteins interacted with full-length
VASP–AD and with those truncated VASP–AD proteins
that contained an intact EVH2 domain but not with
VASP1–304–AD. Further experiments with analogous
Mena and Evl constructs indicated that the EVH2
domain is responsible for homomultimerization and het-
eromultimerization of the VASP, Mena and Evl proteins
(see Table 1).
When PtK2 cells were transfected with a plasmid express-
ing GFP–VASP14–380 and subsequently infected with
L. monocytogenes EGD, fluorescence was detected on bacte-
ria (Figure 1f). This suggested that in the absence of a
functional EVH1 domain, the EVH2 domain is capable of
binding to endogenous VASP and Mena. Substantiating
this hypothesis, GFP–VASP14–304 was diffusely distributed
throughout the cytoplasm and no accumulation was
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Figure 1
Fluorescence micrographs of PtK2 cells transiently transfected with
constructs expressing various VASP, Mena and Evl derivatives fused to
GFP. Cells were transfected with the following constructs: (a) full-
length GFP–VASP; (b,b′) GFP–VASP1–116; (c,c′) GFP–Mena1–114;
(d,d′) GFP–Evl1–117; (e,e′) GFP–VASP1–98; (f,f′) GFP–VASP14–380;
and (g,g′) GFP–VASP14–304, and subsequently infected with L. mono-
cytogenes EGD. (a–g) Distribution of the transiently expressed GFP
fusion proteins; (b′–g′) distribution of actin, shown by phalloidin
staining of the cells in (b–g). (a) In infected cells, full-length
GFP–VASP1–380 was concentrated in focal contacts (enlarged in inset
a′) and on the surface of intracellular L. monocytogenes. On motile
Listeria, VASP was concentrated at the interface between the bacterial
pole and the actin tail (enlarged in inset a′′). (b–d,b′–d′) GFP fusion
proteins bearing only the EVH1 domain of either VASP, Mena or Evl
were still recruited to the bacterial surface. (e,e′) No further binding
was detectable when the carboxy-terminally truncated derivative
GFP–VASP1–98 was used, whereas (f,f′) the amino-terminally
truncated protein GFP–VASP14–380 was able to decorate Listeria,
probably as a result of EVH2-mediated multimerization between the
transiently expressed VASP protein and endogenous Ena/VASP
proteins. (g,g′) No binding could be observed when GFP–VASP14–304,
which is truncated at both termini, was used. Note that the brightness
has been enhanced in (a′,e,g) and reduced in (a′′) to improve
visualization of focal contacts, bacteria or the polarized distribution of
GFP–VASP. Bars represent 10 µm in (a) and 2 µm in (b–g).
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Figure 2
Affinity-binding assay using in vitro translated 35S-labeled derivatives
of Mena, Evl, VASP with ActA immobilized on Affigel. Bound protein
was released by boiling in sample buffer and analyzed by SDS–PAGE
and autoradiography. I, protein input applied to the affinity matrix; B,
protein retained by the Affigel (for example, bound to ActA).
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detectable either on intracellular bacteria or in focal con-
tacts (Figure 1g).
To identify residues within the minimal EVH1 domain
that are crucial for interacting with proline-rich ligands,
we generated a hydrophobicity plot and found two dis-
tinct potentially surface-exposed hydrophilic regions,
which we termed RI and RII (Figure 3). To select amino-
acid residues for site-directed mutagenesis, we relied on
structural analysis performed previously with SH3
domains and their proline-rich ligands [8]. SH3 domains
are composed of numerous hydrophobic and aromatic
amino acids (for example, each has a hydrophobic pocket
embedded in a hydrophilic area containing acidic
residues), whereas their ligands carry basic amino acids
adjacent to prolines [8]. Several highly conserved aromatic
residues are also present in the RI and RII regions of the
different EVH1 domains. The core EVH1-binding motif
FPPPP — previously also termed the ABM1 homology
sequence [9] — is, however, flanked by acidic residues in
the natural ligands ActA (SFEFPPPPTDEEL), vinculin
(EPDFPPPPPDLEQ) and zyxin (EEIFPSPPPPPEEEG)
[6,10,11]. We therefore anticipated that, unlike SH3
domains, EVH1 domains should harbor basic residues in
close vicinity to the aromatic amino acids. Indeed, inspec-
tion of the RI and RII regions revealed several conserved
basic residues that might form salt bridges with acidic
residues within the EVH1 ligand (Figure 3). Using the
yeast two-hybrid system, we found that substitutions
within RI or RII completely abolished binding to ActA,
whereas mutations located outside RI and RII had no
effect (Table 2). These results were further corroborated
by the in vitro affinity-binding assay (data not shown) and
by expressing, in Listeria-infected cells, a GFP–VASP
fusion protein in which the Phe79 and His80 residues of
VASP were replaced by Leu and Asp, respectively
(GFP–VASPF79L/H80D; see Supplementary material pub-
lished with this paper on the internet).
We next considered whether the specific charges of the
residues flanking the ActA polyproline motif were essen-
tial for binding to VASP. A set of five 15-mer peptides
corresponding to the ActA polyproline motif
(S1F2E3F4P5P6P7P8T9D10E11E12L13R14L15) was synthe-
sized on a cellulose membrane in such a way as to sequen-
tially replace the acidic residues Glu3, Asp10, Glu11 and
Glu12 by arginines, and incubated with radiolabeled
VASP. As expected, strong binding was observed to the
peptide corresponding to the wild-type ActA motif
(Figure 4a, column i). Binding to the remaining four pep-
tides was reduced by 66% to 86% (Figure 4a,
columns ii–v), revealing the pivotal role of the acidic
patches flanking the polyproline core motif. We next
examined the influence of a corresponding change in the
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Figure 3
Hydropathy profile of the predicted amino-acid sequences of the EVH1
domains of VASP, Mena and Evl. The bars RI and RII indicate
hydrophilic regions, which are highly conserved in all three proteins as
shown in the alignment of amino-acid sequences. Green, conserved
aromatic residues; pink, conserved basic amino acids.
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Figure 4
Binding of (a) wild-type VASP and
(b) VASPK21E/R22E to immobilized synthetic
15-mer peptides corresponding to the core
EVH1-binding motif within ActA. Each acidic
amino acid within the sequence
SFEFPPPPTDEELRL was replaced by a
basic arginine in succession (i–v) as indicated
by blue residues. Peptides synthesized on a
membrane were incubated with in vitro
transcribed/translated (a) [35S]VASP or
(b) [35S]VASPK21E/R22E, and subjected to
autoradiography. The insets (a′,b′) show the
spot intensities; the contrast in b′ was
increased relative to a′ to improve
visualization of the respective binding
differences. Experiments were performed in
triplicate; Standard deviations are indicated
by error bars.
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charged residues within the EVH1 domain on its binding
to the same set of peptides. The yeast two-hybrid analysis
presented above (see Table 2) demonstrated that the sub-
stitution of the basic residues Lys21 and Arg22 of the
EVH1 domain by neutral alanines abolished binding. We
speculated that this was due to the loss of positively
charged residues that would normally interact with the
negatively charged residues of the ligand. If this were the
case, introduction of negatively charged residues at these
positions would be expected to partially reverse the
binding properties of such a variant. A VASP mutant in
which the residues Lys21 and Arg22 were replaced by
glutamate (VASPK21E/R22E) was therefore generated, and
indeed was no longer able to bind to the polyproline motif
SFEFPPPPTDEELRL of ActA, possibly as a result of
repulsion effects of like charges. This mutant now exhib-
ited a significant interaction with the peptide SFEF-
PPPPTDRELRL, indicating that simple reversal of
charges in key amino acids in either the binding domain
or the ligand affects substrate specificity (Figure 4b). 
Our data point to many common features between EVH1
and SH3 domains that are fundamental for binding to
their respective proline-rich ligands. Like SH3 domains,
EVH1 domains bind short, contiguous and stereotypical
peptide sequences. The main difference, and the most
probable reason why EVH1 domains fail to bind all SH3
ligands tested so far [6], is the reverse distribution of
charged residues in ligands and binding domains that are
necessary for forming salt bridges to stabilize the
hydrophobic interactions, as suggested previously [9].
Whereas acidic residues of SH3 domains interact with
basic residues of their ligands, EVH1 domains use posi-
tively charged residues to establish electrostatic interac-
tions with negatively charged residues present in its
ligands ActA, vinculin and zyxin (for a model, see Supple-
mentary material). Although we have produced artificial
EVH1 variants that are ‘reverse-charged’, we suspect that
such natural variant modules, that engage ligands with
specificities similar to those we have defined above, may
exist within the cell.
Supplementary material
Additional figures showing yeast two-hybrid data, fluorescence micro-
graphs of PtK2 cells expressing GFP–VASP mutants, a model for the
binding of the ActA polyproline motif to the EVH1 domain, and additional
methodological details are published with this paper on the internet.
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Table 2
Interactions of mutated VASP derivatives with themselves and
with ActA derivatives.
VASP–AD + – + +
VASP-NR10A/M14C–AD + – – –
VASP-NK21A/R22A–AD RI – – – –
VASP-NW23T–AD RI – – – –
VASP-NF33T–AD + – – –
VASP-NY39T/N41S–AD + – – –
VASP-NF79L/H80D–AD RII – – – –
VASPF79L/H80D–AD RII – – + +
VASP-N contains residues 1–116 of VASP; it was chosen because it
displayed very strong binding to ActA in the yeast two-hybrid system.
The VASP-N fusion proteins carry single or double amino-acid
substitutions and have been designated accordingly; the domain
containing the mutation(s) is indicated in the first column. Only
substitutions within the RI and RII regions completely abolished
binding. The full-length mutant protein VASPF79L/H80D–AD interacted
with full-length VASP–BD and with VASP227–380–BD through their
EVH2 domains, whereas binding to ActA–BD was not detectable.
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Supplementary materials and methods
Plasmid construction
The various DNA fragments encoding VASP, Mena, Evl or ActA were
generated by PCR using, as templates, a VASP EST clone (GenBank
accession number AA491171, IMAGp998L102036, RZPD, Berlin),
Mena and Evl cDNA clones [S1], or genomic DNA from Listeria
monocytogenes, respectively. Amplification primers were designed so
that the resulting truncated protein began at amino-acid residues 1,
56, 106 or 227 for VASP; 1, 66, 95 or 355 for Mena; 1 or 210 for Evl;
7 for ActA; and ended at amino-acid residues 79, 98, 116, 149, 192,
304 or 380 for VASP; 96, 114, 154, 196 or 541 for Mena; 96, 117,
148 or 393 for Evl; 263, 332 or 422 for ActA. The numbers represent
positions of amino acids according to the published sequences of
Supplementary material
Figure S1
Interaction of various derivatives of
(a) VASP, (b) Mena and (c) Evl with each
other and with ActA (blue) as determined by
the yeast two-hybrid system. Results of X-gal
staining are shown on the right — blue
colonies (which appear black in this figure)
indicate an interaction; white colonies
indicate no interaction. The numbers indicate
amino-acid positions. 
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VASP [S2]; Mena and Evl [S1]; and ActA [S3]. The plasmid vectors
pAS1 and pACTII, which have been described [S4], were cut at the
unique NcoI and BamHI sites located at the 3′ end of sequences
encoding the GAL4 DNA-binding domain and the GAL4 activation
domain, respectively. The VASP, Mena or Evl PCR fragments were
digested with NcoI and BamHI and inserted into the pACTII or pAS1
vector. ActA PCR fragments were digested with NcoI and BamHI or
BglII. For digestion of the fragment encoding ActA7–422, the natural
internal Sau3AI site corresponding to the amino-acid residue 422 was
used. All ActA fragments were cloned into the pAS1 vector. The
pMT7HE plasmid [S5] was modified to generate a NcoI site in the mul-
tilinker region corresponding to those of pACTII and was used for liga-
tion of the different NcoI–BamHI fragments of VASP, Mena or Evl. The
pEGFP-C2 and pEGFP-N1 plasmids (Clontech) were digested at the
unique HindIII and BamHI sites located at the 3′ and 5′ end of the
EGFP gene, respectively. The VASP, Mena or Evl constructs in
pMT7HE were double digested with HindIII and BamHI, inserts purified
from agarose gels and used for ligation into the pEGFP-C2 and
pEGFP-N1 plasmids. The mutant VASP plasmids were constructed
either by fusing fragments encoding mutated VASP80–380 to the 3′ end
of VASP1–79 gene in the former cloned plasmid, or by using the PCR
site-directed mutagenesis method as described [S6]. Therefore, PCR
was used to generate two DNA fragments having overlapping ends in
which site-directed mutations due to nucleotide changes within the
primers were introduced. These fragments were combined in a subse-
quent ‘fusion’ PCR reaction, leading to a fusion product in which the
mutated nucleotides had been incorporated. For the first PCR reaction,
a primer located upstream of the VASP gene was used in combination
with the following 3′ primers: 5′-AAAGCACCACAGTGGC-
CGCGCTGGAAC-3′; 5′-GCAGGGAGCCATGCCGCGTTGCC-3′;
5′-GCAGGGAGCGTTCGCTTGTTGCC-3′; 5′-GCGGCTGGTGGC-
CTGGGGACCCGT-3′; 5′-GCTGTGGGTGATCTGGACGCGGCT-
GAAG-3′; and 5′-AGGGAGCCATTCCTCGTTGCCATCATCATA-3′
to generate amino-terminal VASP fragments encoding proteins
mutated at amino-acid residues 10 and 13; 21 and 22; 23; 33; 39 and
41; and 21 and 22, respectively. The carboxy-terminal VASP fragments
mutated in the same nucleotides were generated using a primer
located downstream of the VASP gene in combination with the follow-
ing 5′ primers: 5′-TGTTCCAGCGCGGCCACTGTGGTGCTTT-3′;
5′-TGGCAACGCGGCATGGCTCCCTG-3′; 5′-TGGCAACAAGCG-
AACGCTCCCTG; 5′-GTCCCCAGGCCACCAGCCGCG-3′; 5′-
CTTCAGCCGCGTCCAGATCACCCACAGCCCCACG-3′; 5′-TAT-
GATGATGGCAACGAGGAATGGCTCCCT-3′. Nucleotides deviating
from the published VASP sequence are indicated in italics. The com-
bined PCR fragment was generated with the same primers used for
constructing plasmids VASP1–116 and VASP1–380. All inserts and fusion
areas of the constructs were verified by sequencing using Taq Dye
Deoxy Terminator cycle sequencing (Applied Biosystems) and analyzed
on an Applied Biosystems 373A automated DNA Sequencer.
Yeast two-hybrid system
The protein interactions were analyzed by the yeast two-hybrid system
as described [S4]. All pAS1 plasmids expressing the GAL4 DNA-
binding domain (amino acids 1–147) fused to the ActA fragments
were transformed into the yeast strain Y187 (MATα, ura3–52, his3,
ade2–101, trp1–901, leu2–3, 112, met–, gal4∆, gal80∆,
URA3::GAL1–lacZ, Clontech) by electroporation and were plated out
onto synthetic complete plates lacking tryptophan (Sc-W). The pACTII
plasmid derivatives expressing the GAL4 activation domain (starting at
amino acid 768) were transformed into yeast strain Y190 (MATα,
ura3–52, his3–200, ade2–101, trp1–901, leu2–3, 112, gal4∆,
gal80∆, URA3::GAL1–lacZ, LYS2::GAL1–HIS3, cyhr2, Clontech)
and plated out on synthetic complete plates lacking leucine (Sc-L). To
examine in vivo interaction between the proteins, the appropriate
S2 Supplementary material
Figure S2
Yeast two-hybrid binding assays using the
indicated constructs which express full-length
VASP or VASP-N (residues 1–116) fused to
AD. VASP-N was chosen because it
displayed very strong binding to ActA in the
yeast two-hybrid system as determined by
β-galactosidase activity. The VASP-N fusion
proteins carry single or double amino-acid
substitutions and have been designated
accordingly; red lines in the schematic
diagram of the proteins indicate the positions
of the substitutions. Only substitutions within
the RI and RII regions (pink) completely
abolished binding. The full-length mutant
protein VASPF79L/H80D–AD interacted with full-
length VASP–BD and with VASP227–380–BD
through their EVH2 domains, whereas binding
to ActA–BD was not detectable.
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transformants were either mated, or the pACTII constructs were trans-
formed into yeast already containing pAS1 constructs. For the mating,
fresh overnight colonies of Y190 and Y187 were picked from Sc-L
and Sc-W plates, respectively, mixed together with a toothpick on a
YPD plate and incubated at 30°C. After 6 h, an inoculum of the mating
mixture was streaked on synthetic complete plates lacking tryptophan
and leucine. For measuring the β-galactosidase activity, multiple
resulting diploid yeast colonies were picked and X-gal tests were per-
formed as described [S7].
Peptide synthesis
Spot synthesis was performed according to Frank [S8] with an Abimed
ASP 222 Automated SPOT Robot.
In vitro interactions
ActA was purified from supernatants of L. monocytogenes as recently
described [S9] and coupled to an Affigel 15 matrix following recom-
mendations by the manufacturer (Biorad); 35S-labeled proteins were
prepared by in vitro transcription/translation of VASP, Mena or Evl DNA
fragments cloned in the pMT7HE vector using the TNT-coupled rabbit
reticulocyte lysate system (Promega). These proteins were diluted
1:100 with incubation buffer (1× PBS, 0.05% Triton X-100, 0.1%
BSA, 2 mM EDTA, 1 mM PMSF), incubated with the Affigel-15-immobi-
lized ActA protein at 4°C with gentle shaking overnight and washed
five times with 15-fold volume of TBS-T (0.2 M Tris-Cl pH 7.6, 137 mM
NaCl, 0.1% Tween-20) at room temperature. Bound protein was
released by boiling in gel sample buffer and separated by SDS–PAGE
in comparison with the input protein. The gel was dried and analyzed
with a phosphorimager (Molecular Dynamics). For peptide spot analy-
sis, radiolabeled proteins were diluted 1:50 with TBS-T and incubated
with the peptide membrane for 2 h with gentle shaking at room temper-
ature. The membrane was washed five times with TBS-T and analyzed
with a phosphorimager.
Transfection of GFP fusion constructs
PtK2 cells (ATCC CCL56) were grown and transfected as described
[S10]; 24 h after transfection, cells were washed once with MEM
medium and infected with L. monocytogenes.
Infection of cultured cells with L. monocytogenes
L. monocytogenes serotype 1/2a EDG were grown in brain–heart infu-
sion broth (Difco) at 37°C with aeration. For infections, bacteria from
an overnight culture were added to PtK2 cells at a dilution of 1:1000
and centrifuged for 2 min with 500g. After 1–2 h, plates were washed
and incubated with fresh medium containing 25 µg/ml gentamycin.
Three hours later, coverslips were washed with PBS, cells were fixed
with 3.7% paraformaldehyde in PBS and permeabilized with 0.2% (v/v)
Triton X-100 in PBS. For localization of actin, cells were incubated with
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Figure S3
Fluorescence micrographs of PtK2 cells transiently expressing 
(a,b) GFP–VASP1–116(F79L/H80D) or (c,d) GFP–VASP1–380(F79L/H80D)
and infected with L. monocytogenes EGD. (a,c) Distribution of GFP
fusion proteins; (b,d) phalloidin staining of the cells shown in (a,c),
respectively. (a,b) In contrast to GFP–VASP1–116 (see Figure 1b in
the paper), the mutated version GFP–VASP1–116(F79L/H80D) was no
longer able to bind to intracellular Listeria. Thus, all three assay
systems indicated that the substitution of the two amino-acid
residues Phe79 and His80 abrogated the interaction between VASP
and ActA in vitro as well as in vivo. Nevertheless, when a full-length
fusion protein, GFP–VASP1–380(F79L/H80D), which carries the same two
substitutions, was expressed, fluorescence could be detected, as
was also observed with the amino-terminally truncated
GFP–VASP14–380 (see Figure 1f in the paper). Both fusion proteins
harbor ‘disabled’ EVH1 domains but still carry a functional EVH2
domain, which is obviously responsible for the targeting. In addition,
actin comet tails showed more intense labeling with
GFP–VASP1–380(F79L/H80D), which might be explained by the recent
finding that the EVH2 domain of VASP interacts with F-actin in vitro
[S12]. The bar in (d) represents 5 µm.
(a)
(d)(c)
(b)
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Figure S4
Model for the binding of the ActA polyproline motif to the EVH1
domain of the Ena/VASP protein family. The hydrophobic interaction
involving the prolines of ActA and distinct aromatic residues of the
EVH1 domain are thought to be responsible for the initial
protein–protein contact. The phenylalanine residue directly preceding
the polyproline cluster is essential for the binding and may serve as a
key residue [S13]. The negatively charged residues flanking the
polyproline core can form salt bridges with distinct positively charged
amino acids (such as Lys21 and/or Arg22) of the EVH1 domain.
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rhodamine-labeled phalloidin. Samples were examined with a Zeiss
Axiovert 135 TV microscope equipped with epifluorescence and a
cooled CCD camera driven by IPLab Spectrum software (Princeton
Instruments). Images were processed using Adobe Photoshop 3.0.
Hydropathy profile
The plots were obtained by standard computer-assisted analysis using
the algorithm and hydropathy values of Kyte and Doolittle [S11].
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